1. Market Research
  2. > Verona Pharma Plc – Product Pipeline Review – 2013

Verona Pharma Plc – Product Pipeline Review – 2013

  • June 2013
  • -
  • Global Markets Direct
  • -
  • 31 pages

Verona Pharma Plc – Product Pipeline Review – 2013

Summary

Global Market Direct’s pharmaceuticals report, “Verona Pharma Plc - Product Pipeline Review - 2013” provides data on the Verona Pharma Plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Verona Pharma Plc’s corporate website, SEC filings, investor presentations and featured press releases, both from Verona Pharma Plc and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Verona Pharma Plc - Brief Verona Pharma Plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Verona Pharma Plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Verona Pharma Plc with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Verona Pharma Plc’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Verona Pharma Plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Verona Pharma Plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Verona Pharma Plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Verona Pharma Plc.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Verona Pharma Plc and identify potential opportunities in those areas.

Table Of Contents

Verona Pharma Plc - Product Pipeline Review - 2013
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Verona Pharma Plc Snapshot 4
Verona Pharma Plc Overview 4
Key Information 4
Key Facts 4
Verona Pharma Plc - Research and Development Overview 5
Key Therapeutic Areas 5
Verona Pharma Plc - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Pipeline Products - Out-Licensed Products 9
Pipeline Products - Partnered Products 10
Verona Pharma Plc - Pipeline Products Glance 11
Verona Pharma Plc Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Verona Pharma Plc - Early Stage Pipeline Products 12
Discovery Products/Combination Treatment Modalities 12
Verona Pharma Plc - Drug Profiles 13
NAIPs 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
RPL-554 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
VRP-700 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Verona Pharma Plc - Pipeline Products by Route of Administration 17
Verona Pharma Plc - Pipeline Products By Mechanism of Action 18
Verona Pharma Plc - Recent Pipeline Updates 19
Verona Pharma Plc - Dormant Projects 24
Verona Pharma Plc - Company Statement 25
Verona Pharma Plc - Locations And Subsidiaries 29
Head Office 29
Other Locations and Subsidiaries 29
Appendix 30
Methodology 30
Coverage 30
Secondary Research 30
Primary Research 30
Expert Panel Validation 30
Contact Us 31
Disclaimer 31

List of Tables

Verona Pharma Plc, Key Information 4
Verona Pharma Plc, Key Facts 4
Verona Pharma Plc - Pipeline by Indication, 2013 6
Verona Pharma Plc - Pipeline by Stage of Development, 2013 7
Verona Pharma Plc - Monotherapy Products in Pipeline, 2013 8
Verona Pharma Plc - Out-Licensed Products in Pipeline, 2013 9
Verona Pharma Plc - Partnered Products in Pipeline, 2013 10
Verona Pharma Plc - Phase II, 2013 11
Verona Pharma Plc - Discovery, 2013 12
Verona Pharma Plc - Pipeline By Route of Administration, 2013 17
Verona Pharma Plc - Pipeline Products By Mechanism of Action, 2013 18
Verona Pharma Plc - Recent Pipeline Updates, 2013 19
Verona Pharma Plc - Dormant Developmental Projects,2013 24
Verona Pharma Plc, Subsidiaries 29

List of Figures

Verona Pharma Plc - Pipeline by Indication, 2013 6
Verona Pharma Plc - Pipeline by Stage of Development, 2013 7
Verona Pharma Plc - Monotherapy Products in Pipeline, 2013 8
Verona Pharma Plc - Out-Licensed Products in Pipeline, 2013 9
Verona Pharma Plc - Partnered Products in Pipeline, 2013 10
Verona Pharma Plc - Pipeline By Route of Administration, 2013 17
Verona Pharma Plc - Pipeline Products By Mechanism of Action, 2013 18

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.